Clinical Trial Update: Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to assess a full-spectrum cannabis extract for refractory epilepsy in patients with tuberous sclerosis complex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis Complex

Drugs mentioned

• Full-spectrum Cannabis Extract (cannabis extract)

Snippet

Sponsor: Oils4Cure | Conditions: Tuberous Sclerosis Complex (TSC) | Phase 3 | Status: RECRUITING